Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats
Its about using a known anti-inflammatory effect of these drugs at the lowest dose that meaningfully improves disease control
A number of studies have shown that treatment with GLP-1s can improve menstrual regularity and, therefore, possibly play a role in treating infertility
A 2025 nutrition review found that high-protein breakfasts reduced afternoon hunger by almost twenty-five percent compared with carbohydrate-heavy ones
Two types of GLP-1RAs, liraglutide and exenatide, were found to be antagonistic to the neurodegeneration and AD progression even in mice without diabetes (35, 49)
When patients lose significant weight on incretin-based therapiesoften 10-15% or more of initial body weight in clinical trials such as the STEP program (semaglutide) and SURMOUNT trials (tirzepatide)the reduction in subcutaneous fat decreases the body's natural insulation layer, making environmental temperatures feel colder than before